Herbal-drug therapy interactions:: A focus on dementia

被引:29
|
作者
Gold, JL
Laxer, DA
Dergal, JM
Lanctôt, KL
Rochon, PA
机构
[1] Baycrest Ctr Geriat Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada
[4] Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Toronto, ON, Canada
[5] Sunnybrook & Womens Coll Hlth Sci Ctr, HOPE Res Ctr, Toronto, ON, Canada
[6] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada
[7] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5S 1A8, Canada
[8] Inst Clin Evaluat Sci, Toronto, ON, Canada
关键词
D O I
10.1097/00075197-200101000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Older people with dementia are often prescribed numerous medications. Use of herbal therapies in addition to these conventional drug therapies may lead to interactions that result in an adverse drug event. We have conducted a systematic review to identify all studies that examined interactions between herbal and conventional drug therapies (i.e. prescription or over-the-counter). Using a MEDLINE search of English-language studies published between 1980 and 2000, we limited our search to those herbal therapies most likely to be used for the treatment of dementia (memory loss and decreased concentration) and related symptoms, We identified 28 articles that describe interactions between these herbal (i.e. St. John's wort, ginkgo biloba, kava, valerian, and ginseng) and conventional drug therapies. Of these articles, 11 examined St. John's wort, four examined ginkgo biloba, five examined kava, one examined valerian, and seven examined ginseng. We identified a series of potential interactions between herbal and conventional drug therapy that place older people at risk for an adverse drug event. Health care professionals need to be aware of these potential interactions. (C) 2001 Lippincott Williams Wilkins.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 50 条
  • [31] Drug Therapy for Patients with Dementia
    Kirsch, Mareike
    von Arnim, Christine
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (04) : 157 - 164
  • [32] Drug therapy of frontotemporal dementia
    Allain, H
    Bentué-Ferrer, D
    Tribut, O
    Mérienne, M
    Belliard, S
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2003, 18 (03) : 221 - 225
  • [33] Antimicrobial drug-drug interactions - Focus on fluoroquinolones
    Stein, GE
    [J]. FIRST INTERNATIONAL MOXIFLOXACIN SYMPOSIUM - BERLIN, 1999, 2000, : 127 - 129
  • [34] Simultaneous determination and pharmacokinetics of protein unbound aspirin and salicylic acid in rat blood and brain by microdialysis: An application to herbal-drug interaction
    Shaw, Lee-Hsin
    Tsai, Tung-Hu
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 895 : 31 - 38
  • [35] An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
    Jose Abad, Maria
    Miguel Bedoya, Luis
    Bermejo, Paulina
    [J]. CURRENT DRUG METABOLISM, 2010, 11 (02) : 171 - 181
  • [36] Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions
    Vazquez, Sara R.
    [J]. BLOOD, 2018, 132 (21) : 2230 - 2239
  • [37] Herbal product-drug interactions mediated by induction
    Tirona, Rommel G.
    Bailey, David G.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (06) : 677 - 681
  • [38] Evidence-based drug-herbal interactions
    Chavez, ML
    Jordan, MA
    Chavez, PI
    [J]. LIFE SCIENCES, 2006, 78 (18) : 2146 - 2157
  • [39] HERBAL MEDICINES: ITS TOXIC EFFECTS AND DRUG INTERACTIONS
    Parmar, Vandana
    [J]. INDIAN ANAESTHETISTS FORUM, 2005,
  • [40] Common Herbal Dietary Supplement-Drug Interactions
    Asher, Gary N.
    Corbett, Amanda H.
    Hawke, Roy L.
    [J]. AMERICAN FAMILY PHYSICIAN, 2017, 96 (02) : 101 - 107